相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The superior predictive value of 166Ho-scout compared with 99mTc-macroaggregated albumin prior to 166Ho-microspheres radioembolization in patients with liver metastases
Maarten L. J. Smits et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Prognostic Factors for Overall Survival in Advanced Intrahepatic Cholangiocarcinoma Treated with Yttrium-90 Radioembolization
Michael Koehler et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Characterization of Liver Metastases During Catheter-Directed Liver Interventions: A Comparison between Dual Phase Cone-Beam Computed Tomography and Conventional Contrast-Enhanced Computed Tomography
Geert Maleux et al.
JOURNAL OF THE BELGIAN SOCIETY OF RADIOLOGY (2020)
Utility of 'dual phase' cone beam computed tomography during radioembolisation in patients with hepatocellular carcinoma: what is really changing in flow dynamics before and after 90Y delivery?
Aysegul Gormez et al.
POLISH JOURNAL OF RADIOLOGY (2020)
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma
Jens Ricke et al.
JOURNAL OF HEPATOLOGY (2019)
Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies
Peter Gibbs et al.
CLINICAL COLORECTAL CANCER (2018)
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
Pierce K. H. Chow et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials
Harpreet S. Wasan et al.
LANCET ONCOLOGY (2017)
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
Valerie Vilgrain et al.
LANCET ONCOLOGY (2017)
Safety and Efficacy of Transarterial Radioembolisation in Patients with Intermediate or Advanced Stage Hepatocellular Carcinoma Refractory to Chemoembolisation
Elisabeth G. Klompenhouwer et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2017)
Biodistribution of 99mTc-MAA on SPECT/CT performed for 90Y-radioembolization therapy planning: a pictorial review
Jason J. Bailey et al.
CLINICAL AND TRANSLATIONAL IMAGING (2017)
Indicators of Lung Shunt Fraction Determined by Technetium-99 m Macroaggregated Albumin in Patients with Hepatocellular Carcinoma
Joseph Ralph Kallini et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2017)
Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J. W. Valle et al.
ANNALS OF ONCOLOGY (2016)
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2016)
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer
Guy A. van Hazel et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Current status of transarterial radioembolization
Andreas H. Mahnken
WORLD JOURNAL OF RADIOLOGY (2016)
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
E. Senkus et al.
ANNALS OF ONCOLOGY (2015)
Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors
Harun Ilhan et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Radioembolization with Y-90 Glass Microspheres: Do We Really Need SPECT-CT to Identify Extrahepatic Shunts?
Jens M. Theysohn et al.
PLOS ONE (2015)
Radioembolisation for liver metastases: Results from a prospective 151 patient multi-institutional phase II study
Al B. Benson et al.
EUROPEAN JOURNAL OF CANCER (2013)
Radioembolisation with Yttrium-90 microspheres: An effective treatment modality for unresectable liver metastases
Lourens Bester et al.
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2013)
Tc-99m-Macroaggregated Albumin Poorly Predicts the Intrahepatic Distribution of Y-90 Resin Microspheres in Hepatic Radioembolization
Maurits Wondergem et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
K. Oberg et al.
ANNALS OF ONCOLOGY (2012)
Transarterial Hepatic Yttrium-90 Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: Factors Associated with Prolonged Survival
Ralf-T. Hoffmann et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2012)
The Significance of 99mTc-MAA SPECT/CT Liver Perfusion Imaging in Treatment Planning for 90Y-Microsphere Selective Internal Radiation Treatment
Hojjat Ahmadzadehfar et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Incorporating Cone-beam CT into the Treatment Planning for Yttrium-90 Radioembolization
John D. Louie et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2009)
分享论文
